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Trust in Scientists and Food Manufacturers:
Implications for the Public Support of
Biotechnology
Harvey S. James, Jr.
An analysis of data from the U.S. Biotechnology Study, 1997S1998 reveals that
few variables affect public trust in scientists, while variables representing
perceived benefits, risks, trustworthiness, and competence affect trust in food
manufacturers on matters of biotechnology. Both trust in scientists and trust in
food manufacturers have a large and important effect on public support for
biotechnology, although trust in scientists is found to be more important than trust
in food manufacturers. Findings of this analysis suggest that trust in scientists is
relatively generalized, while trust in food manufacturers is particularized.
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We might expect a relationship between the trust people place in biotechnology
institutions and the support they are willing to give to biotechnology research and
commercialization. For example, many scholars believe low public support for
biotechnology is a sign of a lack of public trust (Brom, 2000; Hampel, Pfenning, and
Peters, 2000). One reason offered is that consumers perceive that biotechnology
institutions have two biases—a reporting bias, which is an incentive to overstate
benefits and understate risks, and a knowledge bias, which is an inability to fully
anticipate all contingencies—when publicly communicating the risks and benefits
of biotechnology research (Eagly, Wood, and Chaiken, 1978; Kasperson, 1986; Renn
and Levine, 1991; Dholakia and Sternthal, 1977; Peters, Covello, and McCallum,
1997). These biases are a reflection of the public’s perceptions of trustworthiness
(e.g., reporting bias) and competence (e.g., knowledge bias), which are recognized
within the literature as necessary for trust formation (Hardin, 2004).
The empirical evidence linking trust to public support for biotechnology and
genetic engineering, however, is mixed. For example, experiments by Frewer and
Shepherd (1994) and Finlay et al. (1999) found little, if any, effect of trust on public
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support, while survey research by Rosati and Saba (2000), Siegrist (2000), and
Priest, Bonfadelli, and Rusanen (2003) showed a positive but weak effect of trust on
public support. As recently argued by James (2003), based on evidence from the
U.S. Biotechnology Study, the low measured effect of trust on public support is
explained by the fact that trust is endogenously determined with public support.
When this endogeneity is controlled for, public trust of biotechnology institutions
is shown to have a large effect on public support for the genetic modification of crop
plants and the application of biotechnology in food production.
This paper extends James’ (2003) study by modeling separately trust in scientists
developing the technology and trust in agribusinesses commercializing it, and by
showing how trust in these particular institutions affects the general support by the
public for biotechnology. The results show that trust in scientists is higher than trust
in food manufacturers, and few variables affect public trust in scientists. In contrast,
variables representing perceived benefits, risks, trustworthiness, and competence
affect trust in food manufacturers on matters of biotechnology. Furthermore, both
trust in scientists and trust in food manufacturers have large effects on public support
for biotechnology, although trust in scientists is found to be relatively more important
than trust in food manufacturers. These findings suggest that trust in scientists is
generalized, while trust in food manufacturers is particularized. As explained below,
these differences in trust in scientists and food manufacturers will have important
implications for the support the public gives, or does not give, to biotechnology
research and applications.
Trust in Biotechnology Institutions
Trust is defined as “the willingness of a party to be vulnerable to the actions of
another party based on the expectation that the other will perform a particular action
important to the trustor” (Mayer, Davis, and Schoorman, 1995, p. 712). According
to this definition, willingness, vulnerability, and expectations are key aspects of trust
and trust formation. Willingness reflects confidence that correctly trusting will result
in benefits for the truster. Vulnerability reflects the perception that losses can arise
when trust is misplaced—i.e., when trust is placed in someone who might (willingly
or unwillingly) exploit that trust. Expectations entail a belief in the trustworthiness
and competence of the person or entity in whom trust is placed, both of which are
necessary for trust. For instance, Hardin (2004, p. 8) states, “Trust depends on two
quite different dimensions: the motivation of the potentially trusted person to attend
to the truster’s interests and his or her competence to do so.”
James (2002) developed a model linking willingness, vulnerability, and
expectations to trust. In his model, individuals trust when the expected benefits from
correctly trusting exceed the expected losses from mistrusting. The expected benefits
exceed expected losses as the losses from mistrusting decrease, the gains from
correctly trusting increase, and the expectation that trust will not be exploited
increases. The expectation of being exploited is assumed to be a function of the
trustworthiness and competence of the person or institution in which trust is placed.James Trust and Public Support of Biotechnology   121
Although previous research has linked these factors to trust (e.g., Hunt and Frewer,
2001; Peters, Covello, and McCallum, 1997; Kasperson, Golding, and Tuler, 1992),
this paper uses a national survey of U.S. households to examine how perceived
benefits, costs, and expectations of trustworthiness and competence affect trust in
specific biotechnology institutions—namely, scientists and agribusiness food
manufacturers.
Public trust of biotechnology institutions can be modeled by the following binary
dependent variable equation:
(1)   Ti ' γNZi % gi,
where Ti ' 1 if we observe trust, and Ti ' 0 if we observe no trust; Zi represents
characteristics of individual i; γ is a vector of parameters; and gi represents unknown
characteristics affecting trust. We observe trust when the expected benefits of
correctly trusting exceed the expected costs of mistrusting, which is a function of
perceived benefits from correctly trusting, perceived losses from mistrusting, and
expectations of trustworthiness and competence. Therefore, the set of explanatory
variables, Zi, should include elements representing individual i’s assessments of the
potential benefits and costs of biotechnology, the trustworthiness and competence
of biotechnology institutions, and other control factors. The probability that indi-
vidual i will trust biotechnology institutions is expected to increase as the perceived
benefits from biotechnology increase, the risks or costs of using biotechnology
decrease, and the likelihood increases that trust will not be exploited through untrust-
worthiness or incompetence, other things being equal.
Public Support for Biotechnology and Trust
Earlier studies have identified a number of factors affecting public support for bio-
technology, such as perceived risks and benefits, uncertainty, the level of under-
standing of biotechnology, and moral beliefs about biotechnology. Although public
trust of biotechnology institutions has been recognized as a factor, some scholars
have argued it is not an important factor (Rosati and Saba, 2000; Siegrist, 2000).
James (2003) points out that previous empirical studies have failed to account for
the endogeneity of trust in models of public support, thus explaining why trust is
often not found to be important. In other words, suppose we model the effect of trust
and other factors on public support for biotechnology by:
(2) Si ' βNXi % δTi % ui,
where Si is a measure of public support, β is a vector of parameters, Xi is a vector of
explanatory variables other than trust, Ti is a dummy variable equal to one if the
individual trusts biotechnology institutions and zero otherwise, δ is a coefficient
measuring the effect of trust on public support, ui is an error term, and i is an index
for individuals where i ' 1,...,N.122   Fall 2006 Journal of Agribusiness
1  Although the data set used here is relatively dated, there is still value in using it to examine the empirical relation-
ship between public trust and public support for biotechnology. Such a study can help identify variables correlated
with trust and support. It can also be used as a basis for assessing changes in factors affecting trust and support, and
the trust-support relationship, over time. This is important because relatively few studies exist with U.S. data on the
question of how public trust is related to public support for biotechnology.
2  The data set is publicly available online to member institutions affiliated with the Inter-university Consortium
for Political and Social Research at the University of Michigan (at http://www.icpsr.umich.edu/). The data set was
made available to the public in November 2000.
If Ti in equation (2) is modeled by equation (1), the error terms gi and ui will be
correlated. The implication is that trust must be treated as an endogenous rather than
exogenous variable in equation (2); otherwise, an estimation of δ will be biased.
According to James (2003), one way of correcting for the endogeneity of trust is to
replace Ti in equation (2) with an instrumental variable expected to be correlated
with Si but not correlated with the error term ui. This is accomplished as follows:
Equation (1) is estimated with a probit analysis; then the predicted probabilities of
Ti, denoted as are inserted into equation (2) in place of Ti, resulting in the ˆ Ti,
following corrected version of equation (2):
(3) Si ' βNXi % δ ˆ Ti % µi.
Equation (3) now provides a means of examining the unbiased effect of trust on
public support for biotechnology. Although James (2003) found that trust in biotech-
nology institutions has a positive and large effect on public support for biotech-
nology, he did not distinguish between trust in different types of biotechnology
institutions. Accordingly, this analysis extends James’ earlier work by examining the
effects of trust in scientists and trust in food manufacturers separately on public
support for biotechnology.
Methods
Data for this study come from the “United States Biotechnology Study, 1997S1998.”
1
This data set was created from telephone interviews of a representative sample of
1,067 U.S. citizens, 18 years of age and older, between November 1997 and
February 1998 (Miller, 2000).
2 Respondents were asked questions regarding their
attitudes toward biotechnology, their knowledge of science, and other questions
related to technology and politics. In this sample, 58.7% of respondents had at least
some post-high school education, 49.8% of respondents were male, and the average
respondent was approximately 45 years old. Because the data for this study come
from a preexisting, publicly available data set, variable and proxy selection are
limited by the type and quality of questions utilized in the survey. Table 1 presents
a description of all variables used in this study.James Trust and Public Support of Biotechnology   123
Table 1. Definitions, Sample Means, and Standard Deviations of Dependent





Trust Scientists Dichotomous variable, =1 if respondent placed a lot or some
trust in a statement by university scientists about biotechnology
0.9035
(0.2955)
Trust Food Manufacturers Dichotomous variable, =1 if respondent placed a lot or some
trust in a statement by food manufacturers about biotechnology
0.5511
(0.4976)
Support Biotechnology Dichotomous variable, =1 if respondent expressed support




Variables in Trust Model:
Will Improve Life Dummy variable, =1 if respondent believes biotechnology or





Dummy variable, =1 if respondent believes biotechnology will





Dummy variable, =1 if respondent believes biotechnology will
likely reduce world hunger
0.4827
(0.4999)
Too Risky Dummy variable, =1 if respondent definitely agreed or tended
to agree that each of the following are risky for society:
(1) use of biotechnology in food and drink,
(2) inserting genes from plants to crops, and
(3) introducing human genes into animals
0.2371
(0.4255)
Likely to Result in New
Diseases
Dummy variable, =1 if respondent believes biotechnology will
likely result in new diseases within the next 20 years
0.6514
(0.4768)
Likely to Reduce Range
of Foods
Dummy variable, =1 if respondent believes biotechnology will





Dummy variable, =1 if respondent strongly agrees or agrees that






Dummy variable, =1 if respondent strongly agrees or agrees that
the biotechnology industry can regulate itself
0.1921
(0.3942)
Too Complex for Policy Dummy variable, =1 if respondent strongly agrees or agrees that
biotechnology is too complicated to be sufficiently regulated
0.1715
(0.3771)
Not Worth Labeling Dummy variable, =1 if respondent strongly agrees or agrees that
it is not worth putting labels on genetically modified foods
0.1603
(0.3670)
Variables in Support Model:
Religious Scale variable ranging from 0 to 10, based on respondent
assessment of how religious he/she is: 0 = not at all religious;





Scale variable ranging from 0 to 10, based on respondent
assessment of how important biotechnology is to oneself:





Scale variable ranging from 0 to 10, based on respondent
assessment of how informed he/she is about biotechnology:
0 = not at all informed; 10 = very well informed
4.6792
(1.9765)





Variables in Support Model (cont’d.):
Negative Feelings About
Biotechnology
Dummy variable, =1 if the respondent has strongly negative or





Number of True/False science questions answered correctly 
(of a total of 8 questions):
(1) DNA regulates inherited characteristics in all plants,
animals, and humans. [True]
(2) Given today’s biotechnology, scientists can now create new
genes that never existed in nature. [False]
(3) More than half of human genes are identical to those with
chimpanzees. [True]
(4) The cloning of living things produces exactly identical
offspring. [True]
(5) Ordinary tomatoes do not contain genes, while genetically
modified tomatoes do. [False]
(6) By eating a genetically modified fruit, a person’s genes
could also become modified. [False]
(7) It is impossible to transfer animal genes into plants. [False]




Control Variables for Trust and Support Models:




Male Dummy variable, =1 if the respondent is male 0.4977
(0.5002)
Age Respondent’s age (years) 44.7
(15.6)
Note: Based on data set provided through “United States Biotechnology Study, 1997S1998” (Miller, 2000).
The Trust Model
Equation (1) describes the relationship between trust and factors expected to affect
trust. Trust in scientists is proxied by a dichotomous variable (Trust Scientists) equal
to one if respondents placed a lot or some trust in a statement by university scientists
about biotechnology. Similarly, Trust Food Manufacturers is a dichotomous variable
equal to one if respondents placed a lot or some trust in a statement about biotech-
nology by food manufacturers. As shown in table 1, 90% of respondents reported at
least some trust in university scientists, while 55% of respondents placed at least
some trust in food manufacturers. Moreover, the standard deviation of trust in
scientists is smaller than the standard deviation of trust in food manufacturers, even
after controlling for the variable means.
In order to examine factors reflecting perceived benefits, costs, and expectations
of trustworthiness and competence on trust, a probit model is estimated in which
trust in scientists and trust in food manufacturers are treated as dependent variables.James Trust and Public Support of Biotechnology   125
Perceptions of benefits of biotechnology are proxied by variables representing
respondent beliefs about whether biotechnology will improve our way of life,
whether biotechnology will likely reduce environmental pollution, and whether
biotechnology will reduce world hunger. In each case, an increase in the variable is
expected to have a positive impact on trust in both scientists and food manufacturers.
Perceptions of risks arising from biotechnology are proxied by variables represent-
ing respondent beliefs about whether biotechnology and genetic engineering is risky,
whether new diseases are likely to emerge because of biotechnology research, and
whether biotechnology will reduce the range of fresh foods available. In each of
these cases, an increase in the variable is expected to have a negative impact on
trust.
The trustworthiness of biotechnology institutions is proxied by a variable indi-
cating whether respondents believe current regulations are sufficient to protect people
from risks and a variable indicating whether respondents believe the biotechnology
industry can self-regulate. Each of these variables is expected to be positively
correlated with improved trustworthiness of university scientists and food manu-
facturers, suggesting they should positively affect trust in these biotechnology
institutions. Competence is proxied by a variable indicating whether respondents
agree that biotechnology is too complex to be adequately regulated, and by a
variable indicating whether respondents agree it is not worth labeling genetically
modified (GM) food. Because a reduction in perceived competence is anticipated to
lower trust, the variable measuring complexity and regulation is expected to be
negative, while the variable representing attitudes toward food labeling is expected
to be positive. (In the latter case, the justification for the labeling variable is that if
respondents do not perceive a need to distinguish between GM and non-GM foods
by means of labels—perhaps because they consider the issue of genetically modified
food not complicated enough to warrant separate labels—then they may not be overly
concerned about the competence of biotechnology institutions to separate GM from
non-GM foods or engage in other activities reflecting or affected by competence.)
The Support Model
Equation (3) describes the relationship between public support and trust, controlling
for the expected endogeneity of trust and other factors likely to affect support. Public
support for biotechnology is proxied by a dichotomous variable equal to one if
respondents expressed support rather than opposition to biotechnology in agriculture
and food production. As observed in table 1, approximately three-quarters of
respondents expressed support for biotechnology.
Siegrist (2000) and Rosati and Saba (2000) reported that increases in perceived
risks tend to reduce public acceptance, while increases in the expected benefits of
biotechnology research improve public acceptance (Wolt and Peterson, 2000;
Hampel, Pfenning, and Peters, 2000). Therefore, variables are included to represent
respondent beliefs that biotechnology will improve life and that biotechnology
is risky. Additionally, Rosati and Saba (2000) found that uncertainty regarding126   Fall 2006 Journal of Agribusiness
biotechnology and moral beliefs affected public acceptance, and Priest, Bonfadelli,
and Rusanen (2003) concluded that attitudes toward science, knowledge of science,
and education level have separate, distinct effects on support for biotechnology.
Hence, a variable measuring the strength of the respondent’s religious beliefs is
included, as well as variables measuring beliefs about how important biotechnology
is to the respondent, how informed the respondent is about biotechnology, and
whether the respondent has negative feelings toward biotechnology. Finally, a vari-
able is included to indicate the level of the respondent’s understanding about bio-
technology and genetic engineering.
Results
Table 2 presents the results of the probit analysis of equation (1), in which trust in
scientists and trust in food manufacturers are regressed on variables representing
benefits, costs, trustworthiness, and competence—factors expected to be important
for trust. Table 3 reports the results of the probit analysis of equation (3), in which
a measure of public support for biotechnology is regressed on predicted trust in
scientists and food manufacturers, controlling for other factors expected to affect
support. The estimated slope, which represents the change in the probability of the
dependent variable for a unit change in the explanatory variable, is calculated by
multiplying the estimated coefficient by the average density function of the standard
normal distribution evaluated for each observation (Greene, 2000).
As revealed by table 2, few variables affect trust of scientists. Indeed, the only
variables significantly correlated with trust in scientists are perceptions of whether
biotechnology will improve life and beliefs that current regulations are sufficient to
regulate biotechnology institutions. Specifically, perceived benefits and expectations
of trustworthiness alone are key factors explaining trust in scientists. However, the
effect of these two variables is relatively small, improving trust by approximately
5% each.
In contrast, trust in food manufacturers is affected by variables representing per-
ceived benefits, perceived costs, expectations of trustworthiness, and expectations
of competence, as predicted. For example, perceptions that biotechnology will result
in improved life, reduced pollution, and reduced world hunger increase trust in food
manufacturers by 8.7%, 5.7%, and 9.9%, respectively, while perceptions that
biotechnology is risky lowers trust by nearly 10%. Moreover, expectations of
trustworthiness appear to be particularly important for trust in food manufacturers.
For instance, respondents who believe the biotechnology industry can regulate itself
(e.g., the industry is trustworthy) show a 19% increase in trust in food manufac-
turers, relative to respondents who do not believe the industry can self-regulate.
Finally, expectations of competence also appear to be important for trust in food
manufacturers, as suggested by the finding that respondents who believe it is not
worth labeling GM foods are 8.6% more likely to trust food manufacturers than
respondents who believe GM foods should be labeled.James Trust and Public Support of Biotechnology   127



























































































Likelihood Ratio (df = 14) 35.4504*** 119.1647***
% Corrected Predicted 66.5%    68.2%  
Average Density 0.1611 0.3605
Notes: Single, double, and triple asterisks (*) denote statistical significance at the 10%, 5%, and 1% levels,
respectively. Estimated slope is calculated by multiplying the coefficient by the average density.128   Fall 2006 Journal of Agribusiness
Table 3. Probit Analysis Results of Support of Biotechnology, Controlling for
Trust and Other Factors
MODEL 1
(Effect of Trust in
Scientists)
MODEL 2
















Trust Scientists (predicted) 5.5762***
(1.3187)
1.4677
Trust Food Manufacturers (predicted) 1.8161***
(0.3834)
0.4765



























































Likelihood Ratio (df = 12) 168.6100*** 173.5975***
% Corrected Predicted 76.5%   76.6%  
Average Density 0.2632 0.2624
Notes: Single, double, and triple asterisks (*) denote statistical significance at the 10%, 5%, and 1% levels,
respectively. Estimated slope is calculated by multiplying the coefficient by the average density.James Trust and Public Support of Biotechnology   129
3  A one standard deviation increase in trust in scientists, 0.2955 (from table 1), multiplied by the percentage
increase in public support per unit change in trust, 1.4677 (table 3), equals 43.4%.
4  A one standard deviation increase in trust in food manufacturers, 0.4976 (from table 1), multiplied by the per-
centage increase in public support per unit change in trust, 0.4765 (table 3), equals 23.7%.
Based on the results reported in table 3, trust in scientists and food manufacturers
has an important effect on public support for biotechnology, even after controlling
for the endogeneity of trust as well as other factors expected to affect public support.
Indeed, of the variables included in this analysis, trust has the largest effect on public
support. For instance, according to the results reported under model 1, which exam-
ines the effect of trust in scientists, a one standard deviation increase in the trust of
scientists improves public support for biotechnology by 43%.
3 Similarly, the results
reported under model 2, which examines the effect of trust in food manufacturers,
indicate a one standard deviation in trust in food manufacturers improves public
support by nearly 24%.
4
Interestingly, the analysis reveals that trust in scientists appears to have a compar-
atively larger effect on public support for biotechnology than trust in food manufac-
turers, despite the few factors affecting this trust (table 2). Additionally, perceptions
that biotechnology is risky lower public support, as do negative feelings for bio-
technology. In contrast, respondents who believe biotechnology is important, who
are informed about biotechnology, who do not have negative feelings toward
biotechnology, or who have a basic knowledge of genetic science are more likely to
support biotechnology. While significant, a belief that biotechnology is important
and being informed about biotechnology produce only a small increase (e.g., between
1% and 2% each) in support. In contrast, one’s feelings regarding biotechnology
affect support for it by more than 7%. Furthermore, a one standard deviation
increase in knowledge of basic genetic science increases support for biotechnology
by approximately 5%.
Discussion
To summarize the findings of this analysis of the U.S. Biotechnology Study,
respondents place relatively high trust in scientists, while trust in food manufacturers
is only moderate. Very few variables are correlated with trust in scientists, while
variables reflecting perceived benefits and costs, and expectations of trustworthiness
and competence, collectively explain trust in food manufacturers. Finally, trust in
scientists has a stronger effect on public support for biotechnology than trust in food
manufacturers.
These findings are curious. One explanation could come from Uslaner’s (2002)
distinction between generalized and particularized trust. Generalized trust is trust
placed in most people; it is relatively stable and is largely unaffected by other
factors, such as regression covariates. This is in contrast to particularized trust,
which is trust placed in specific institutions or institutions associated with certain
characteristics. As such, particularized trust would be affected by institutions or130   Fall 2006 Journal of Agribusiness
individual characteristics, and hence would be relatively more affected by covariates
than generalized trust. This characterization fits the data presented here, since not
only are few variables (e.g., only two in this study) correlated with trust in scientists,
but also most people trust scientists—and the variability (mean adjusted standard
deviation) in that trust is low, especially when compared to trust of food manufac-
turers. Thus, trust in scientists might be relatively more generalized than trust in
food manufacturers.
According to Uslaner (2002), generalized trust is important for the development
of social capital, which in turn is necessary for the functioning of democratic and
market-oriented societies. Consequently, if trust in scientists is generalized, then
trust in scientists should have important benefits to society generally, especially in
the context of potentially controversial issues such as biotechnology research and
applications to food, medicine, and other consumer products. The data appear to be
consistent with this argument. Trust in scientists has a comparatively larger effect
on public support for biotechnology than trust in food manufacturers (see table 3).
This will likely have important implications for the public support of biotechnology,
since information the public receives about biotechnology often comes from the
scientists engaged in the research. This finding is also consistent with previous
investigations showing that scientists are regarded by both the public and other
scientists as most likely to tell the truth about biotechnology (see Lang, O’Neill, and
Hallman, 2004; Lang and Hallman, 2005). Hence, even if there are negative stories
about biotechnology (e.g., reports of GM contamination of non-GM foods or crops),
information reported by scientists might still be regarded as reliable.
In contrast, trust in food manufacturers is affected by a full range of variables
reflecting public perceptions of risks and benefits, as well as perceptions of
trustworthiness and competence, suggesting trust in food manufacturers is particu-
larized—i.e., it is affected by specific institutional or individual characteristics. This
is not too surprising, since it is from food manufacturers that we get our food. Survey
respondents qua consumers are closer to food manufacturers than to scientists along
the value chain, and food manufacturers probably have a greater impact on food
safety than scientists, implying that public perceptions of risks, benefits, trustworth-
iness, and competence ought to be more salient in the case of food manufacturers
than for scientists.
While perceived risks and benefits are important, perceptions of trustworthiness
and competence are especially important in the case of particularized trust, since
these are necessary, though not sufficient, for trust formation. By necessary, it is
meant that if one is absent, trust will not exist; however, the presence of either aspect
does not guarantee the existence of trust. Thus, any information (related to biotech-
nology or not) calling into question the perceived trustworthiness or competence of
food manufacturers could reduce public trust in them with respect to biotechnology
(Slovic, 1993). For instance, public announcements of biotechnology problems (such
as GM contamination of human food products) can have negative impacts on trust,
even though the trustworthiness of biotechnology institutions is not an issue.James Trust and Public Support of Biotechnology   131
Conversely, questions of trustworthiness, which might arise because of corporate
accounting scandals of both biotechnology and non-biotechnology companies, could
also destroy trust, independent of the perceived competence of the firms and the
actual risks and benefits of biotechnology. Therefore, in order to foster public trust,
and hence foster public support for biotechnology, food manufacturers should be
particularly careful in the actions they take so that perceptions of trustworthiness and
competence are strengthened rather than weakened.
This study has also shown that trust in scientists and trust in food manufacturers
have a large and important effect on public support for biotechnology. Indeed, trust
is shown to be more important than perceptions of risks or benefits alone. This
finding is in contrast to other studies reporting a weak link between trust and public
support. There are several possible explanations for this finding. First, because much
of the previous empirical work on the trust and support relationship is based on
European data, there might be differences between U.S. and European respondents
with respect to public trust and support. Indeed, U.S. consumers are generally more
accepting of biotechnology than Europeans (Sittenfeld and Espinoza, 2002), and
these differences are likely apparent in how survey respondents answer questions
regarding trust and public support. Second, previous research may not have accurately
identified and corrected for an expected endogenous relationship between trust and
public support for biotechnology (James, 2003). A third explanation is that studies
examining the trust and support relationship use different measures of trust. For
example, Priest, Bonfadelli, and Rusanen (2003) measure trust as a belief that the
entity is “doing a good job for society.” This is in contrast to the direct measure of
trust used here, defined as the respondent having a lot or some trust in a statement
by the entity about biotechnology. Unfortunately, there is no generally accepted
definition of trust, which is problematic with research designed to examine the
relationship between trust and other factors.
Concluding Comments
Given the inevitably increasing scientific advances of biotechnology research, an
understanding of the relationship between trust and public support is important in
guiding the social debate over GM foods and the role of biotechnology in food
production. If public trust is a factor affecting public support for biotechnology, and
if it is as varied and important as this research suggests, then more effort should be
placed on examining (a) what it means to say there is trust in biotechnology institu-
tions; (b) how trust ought to be measured; (c) why trust in biotechnology institutions
is or is not affected by perceptions of risks, benefits, trustworthiness, and compe-
tence; and (d) whether the relationship between trust and public support, as well as
factors affecting trust and public support, change over time.132   Fall 2006 Journal of Agribusiness
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